PROFILE |
 |
If invasive clinical tests make you so impatient you could just spit, you might be interested in Trinity Biotech's saliva- and blood-based tests. The company makes and markets more than 200 diagnostic products utilizing immunoassay technologies in some 80 countries. The company's products are used to test for autoimmune and hormonal disorders, respiratory infections, cardiovascular disease, lyme disease, and several STDs, among other disorders and infectious diseases. Trinity Biotech's growth has been bolstered by acquisitions, including Clark Laboratories, Cambridge Diagnostics' HIV product line, Dade Behring's Microtrak STD product line, MarDx Diagnostics, and Bartels, a division of Intracel.
COMPETITION |
 |
OraSure Technologies, Inc. (OSUR)
Quidel Corporation (QDEL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 29.70
1-Yr. Sales Growth: 13.8%
Employees: 306
Revenue per employee: $97,058.82
KEY PEOPLE |
 |
Ronan O'Caoimh
CEO
Maurice Hickey
CFO
CONTACT INFO |
 |
IDA Business Park
Bray Co. Wicklow, Ireland
Phone: 353-1276-9800
Fax: 353-1276-9888
Online: Web Site
|